Safety evaluations for anti-infective therapies

Ended Definitive Contract Awarded Last action

Contract number
00266200007D266005417
Awardee
Awarding agency
Obligated
$15,827,819

Award facts

Contract value 62% obligated
  • $19,608,575.00 Current, with exercised options
  • $25,378,188.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 10 $0
Funding Only Action 9 $750,000
Funding Only Action 8 $2,473,133
Funding Only Action 7 $3,916,229
Supplemental Agreement for work within scope 6 $2,018,992
Supplemental Agreement for work within scope 5 $1,637,465
Supplemental Agreement for work within scope 4 $1,675,000
Supplemental Agreement for work within scope 3 $1,800,000
Original award $1,557,000

About this award

This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $25,378,188.00 contract is for safety evaluations of anti-infective therapies, with a period of performance ending on July 30, 2007. Sri International, which has expertise across various scientific and engineering disciplines, frequently serves as a prime contractor and subcontractor on federal R&D contracts and grants. This contract does not have a small business set-aside. Sri International also holds multiple indefinite delivery vehicles (IDVs) with federal agencies like the Department of Defense, NASA, and NIH, which allow for the efficient procurement of its research and technical services across a wide range of domains.

Quick answers

Who was awarded contract 00266200007D266005417?

00266200007D266005417 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2000.

How much is contract 00266200007D266005417 worth?

The government has obligated $15,827,819 on 00266200007D266005417. Its current value, with exercised options, is $19,608,575. Its potential value, with all options, is $25,378,188.

Was contract 00266200007D266005417 competed?

The extent of competition for 00266200007D266005417 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award